Generic Name: Influenza virus vaccine

  • What is FluLaval?

    FluLaval is an influenza virus vaccine indicated for active immunization of adults 18 year and older against influenza disease caused by influenza virus subtypes A and type B contained in the vaccine.
  • What is the most important information I should know about FluLaval?

    If Guillain-Barre syndrome (an uncommon inflammatory disorder in which your body's immune system attacks your nerves, typically causing severe weakness and numbness) has occurred within 6 weeks of receipt of a prior influenza vaccine, the decision to give FluLaval should be based on careful consideration of the potential benefits and risks.

    Individuals with bleeding disorders or receiving anticoagulants are at risk of hematoma (internal bleeding) formation following a FluLaval injection.

    Patients lacking an adequate immune response may have a reduced immune response to FluLaval.

  • Who should not take FluLaval?

    FluLaval is not indicated for use in children.

    FluLaval is contraindicated in patients who are known to have allergic reactions to egg proteins (eggs or egg products), chicken proteins, or any ingredient of FluLaval. Also, it is contraindicated if the patient had any life-threatening reaction to previous influenza vaccination.

    Immunization should be delayed in a patient with an acute neurologic disorder but should be considered when the disease process has been stabilized.

  • What should I tell my doctor before I take the first dose of FluLaval?

    Tell your doctor about all prescription, over-the-counter, and herbal medication you are taking before beginning treatment with FluLaval. Also, talk to your doctor about your complete medical history, especially if you have allergic reactions to egg or chicken proteins, are pregnant or planning to become pregnant, or if you have a history of any neurologic disorder.
  • What is the usual dosage?

    The information below is based on the dosage guidelines your doctor uses. Depending on your condition and medical history, your doctor may prescribe a different regimen. Do not change the dosage or stop taking your medication without your doctor's approval.

    A single 0.5 mL intramuscular injection preferably in the region of the deltoid muscle of the upper arm.

  • How should I take FluLaval?

    Inspect FluLaval for any particular matter or discoloration prior to administration. Shake the vial vigorously each time before withdrawing a dose of vaccine. A separate sterile syringe and needle should be used for each injection to prevent transmission of infectious agents. A needle length of greater than 1 inch is preferred because needles less than 1 inch might be of insufficient length to penetrate muscle tissue in certain adults.
  • What should I avoid while taking FluLaval?

    Avoid exposing yourself to known sources of infection.
  • What are possible food and drug interactions associated with FluLaval?

    If FluLaval is taken with certain other drugs, the effects of either could be increased, decreased, or altered. It is especially important to check with your doctor before combining FluLaval with any of the following: phenytoin, theophylline, and warfarin.
  • What are the possible side effects of FluLaval?

    Side effects cannot be anticipated. If any develop or change in intensity, tell your doctor as soon as possible. Only your doctor can determine if it is safe for you to continue taking this drug.

    Side effects may include: pain, redness, swelling at the injection site, headache, fatigue, low grade fever

  • Can I receive FluLaval if I am pregnant or breastfeeding?

    The effects of FluLaval during pregnancy and breastfeeding are unknown. Tell your doctor immediately if you are pregnant, plan to become pregnant, or are breastfeeding.
  • What should I do if I miss a dose of FluLaval?

    Most people need only one dose of this medicine.
  • How should I store FluLaval?

    Store the vial in refrigerator at 2° and 8°C (36° and 46°F). Do not freeze. Discard if the vaccine has been frozen. Once entered, a multi-dose vial, and any residual contents, should be discarded after 28 days.